National Vaccine Evaluation Consortium
The National Vaccine Evaluation Consortium (NVEC) conducted a large number of clinical trials over several decades, ceasing existence at the end of 2018. Details of these trials can be found in the 'past studies' section below.
If you have a question or need advice in relation to these studies, please contact Dr Elizabeth Coates in the Public Health England (PHE) Research and Development (R&D) office elizabeth.coates@phe.gov.uk
Role
The National Vaccine Evaluation Consortium (NVEC):
- evaluated new vaccines and vaccination schedules to inform decisions about vaccinations given by the NHS
- provided this information to the Department of Health using data from clinical trials in adults, children and babies
- assisted the Department of Health in developing the UK national immunisation schedule
In partnership with universities and NHS researchers, NVEC members were experts in their field: doctors, laboratory scientists, epidemiologists, nurses, statisticians and data managers. Some partners were involved in all studies, some in particular pieces of work only.
NVEC coordinated most of its clinical trials at PHE through the Immunisation, Hepatitis and Blood Safety Health Protection Service. The trials took place at PHE clinical hubs in Gloucestershire and Hertfordshire.
Past clinical trials
NVEC trials assess the likely effect on people of a new vaccine when it is introduced. Find out more about clinical trials on NHS Choices.
Flushed
PRIME follow up
HPV follow up
Find out about the HPV follow up.
Multiboost
Find out about Multiboost vaccine trial.
Sched3
Hepatitis B vaccination in infants (Infanrix)
iMAP2
Pneumococci in the nose (PIN)
LAIV immuno
For more information about past clinical trials, see The National Archives.